JMP Securities Downgrades Vitae Pharmaceuticals (VTAE) to Market Perform
Tweet
Share
E-mailGet Alerts VTAE Hot Sheet
Price: $21.00 --0%
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
JMP Securities downgraded Vitae Pharmaceuticals (NASDAQ: VTAE) from Market Outperform to Market Perform.
For an analyst ratings summary and ratings history on Vitae Pharmaceuticals click here. For more ratings news on Vitae Pharmaceuticals click here.
Shares of Vitae Pharmaceuticals closed at $15.19 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GLJ Research Downgrades Fluence Energy Inc. (FLNC) to Hold
- CIBC Downgrades Bank of Montreal (BMO:CN) (BMO) to Neutral
- Citi cuts TJX Companies rating to Neutral, lowers price target
Create E-mail Alert Related Categories
DowngradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
